Rani Therapeutics Holdings, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RANI Nasdaq 2830 www.ranitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rani Therapeutics Holdings, Inc.

Rani Therapeutics to Participate in Upcoming September Conferences - Sep 8th, 2026 6:00 am
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalysts - Aug 27th, 2026 10:44 pm
Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline - Aug 16th, 2026 2:01 pm
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update - Aug 13th, 2026 2:05 pm
Rani Therapeutics Appoints Michelle Gilson to Board of Directors - Aug 4th, 2026 6:00 am
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jul 20th, 2026 2:05 pm
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing - Jul 15th, 2026 6:00 am
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates - Jul 9th, 2026 2:05 pm
Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer - Jun 29th, 2026 6:00 am
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules - May 26th, 2026 6:00 am
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition - May 15th, 2026 2:05 pm
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference - May 12th, 2026 2:05 pm
This Rani Therapeutics Holdings Insider Increased Their Holding By 9,754% Last Year - May 8th, 2026 5:11 am
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy - Apr 9th, 2026 5:00 am
Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth - Mar 28th, 2026 6:00 am
Rani Therapeutics Q4 Earnings Call Highlights - Mar 26th, 2026 3:48 pm
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update - Mar 26th, 2026 2:05 pm
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization - Mar 25th, 2026 2:53 pm
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results - Mar 19th, 2026 2:05 pm